2019 American Transplant Congress
Clostridium difficile Infection Mimics Intestinal Acute Cellular Rejection in Pediatric Multivisceral Transplant – A Case Series
*Purpose: Clostridium difficile infection (CDI) is the most common healthcare-associated infection in the United States. One out of 8 recipients who undergo transplantation with more…2018 American Transplant Congress
Risk of Bacteremia According to Transplant Induction Immunosuppression Regimen
University of Wisconsin School of Medicine and Public Health, Madison.
Background: Transplant immune suppression is designed to suppress the adaptive immune response and ensure graft survival, but may have unintended effects on innate immunity. Few…2018 American Transplant Congress
Association of Immunosuppressive Therapy Regimen with Sepsis Outcomes among Kidney Transplant Recipients
OBJECTIVE: Immunosuppressive therapy (IST) could impact sepsis outcomes by altering the host immune response. We examined the associations of IST regimens with sepsis outcomes among…2018 American Transplant Congress
The Impact of Spontaneous Bacterial Peritonitis on Patient Outcomes after Liver Transplantation Using the Scientific Registry of Transplant Recipient (SRTR) Database
Spontaneous bacterial peritonitis (SBP) is associated with abdominal inflammation and increased morbidity in patients with end-stage liver disease. However, SBP has generally not been associated…2018 American Transplant Congress
Primary Oral Vancomycin Prophylaxis Reduces the Incidence of Clostridium difficile Infection among Lung Transplant Recipients
Cleveland Clinic Foundation, Cleveland, OH.
Purpose: To determine the efficacy of primary oral vancomycin prophylaxis in reducing the incidence of Clostridium difficile infection (CDI) in the early post-op period among…2018 American Transplant Congress
Mycoplasma hominis Infection in Lung Transplant Recipients: A Retrospective Case Series
1UHN, Toronto, ON, Canada; 2University of Toronto, Toronto, ON, Canada; 3UC-San Diego, San Diego.
Background: Mycoplasma hominis is increasingly recognized as a respiratory pathogen causing invasive disease in solid organ transplant (SOT) recipients. We reviewed the clinical characteristics, management…2018 American Transplant Congress
Safety and Tolerability of Therapy for Latent Tuberculosis Infection: A 16-Year Review
Transplant Infectious Diseases, UHN, Toronto, ON, Canada.
Introduction:Screening and therapy of latent tuberculosis infection (LTBI) is recommended in transplant candidates. However, data on therapy of LTBI with fluoroquinolones are limited. We aimed…2018 American Transplant Congress
Impact of Positive Donor Blood Cultures in Liver Transplant Recipients
Emory University Hospital, Atlanta, GA.
The purpose of this study was to describe the bacteremia transmission rate of transplanting livers from donors with positive bacterial blood cultures into liver transplant…2018 American Transplant Congress
Identifying Differences in Antimicrobial Resistance with a Liver Transplant Antibiogram
Methodist Dallas Medical Center, Dallas.
Regulatory requirements for antimicrobial stewardship pose a unique challenge in special populations including transplant recipients. Infection following liver transplant can adversely impact patient outcomes. Moreover,…2018 American Transplant Congress
Colistin (COL) in Solid Organ Transplant Recipients (SOTR): Friend or Foe?
Cleveland Clinic, Cleveland, OH.
Background: Data on COL use in SOTR are lacking. In other populations, high dose (HD) COL (>4.4mg/kg/day) has been associated with clinical and microbiologic cure…
- « Previous Page
- 1
- …
- 5
- 6
- 7
- 8
- 9
- …
- 12
- Next Page »